Table 3 Group comparisons following the nearest neighbor matching process
Characteristic | Treatment ≥5 days (n = 32) | No Treatment (n = 32) | p-value |
|---|---|---|---|
Age mean (±SD) | 58.0 (±15.7) | 57.3 (±11.5) | 0.892 |
Sex (mean) | 26 (81%) | 24 (75) | 0.762 |
ICU | 11 (34%) | 10 (31%) | 1.000 |
Internal medicine | 11 (34%) | 12 (38%) | 1.000 |
Malignancy | 13 (41%) | 11 (34%) | 0.796 |
Hematologic cancer | 3 (9%) | 2 (6%) | 1.000 |
Immunosuppression | 5 (16%) | 5 (16%) | 1.000 |
Renal failure | 5 (16%) | 7 (22%) | 0.749 |
CCI, mean | 4.3 | 4.1 | 0.109 |
Any surgical treatment | 21 (66%) | 18 (56%) | 0.608 |
Orthopedic hardware or intravascular prosthetic material | 10 (31%) | 8 (25%) | 0.781 |
Fever (> 38.2 °C) | 19 (59%) | 17 (53%) | 0.801 |
Catheter type: short-term | 29 (91%) | 30 (94%) | 1.000 |
Primary endpoint (Non-resolved Infection) | 5 (16%) | 0 (0%) | 0.062 |